Riskpilot← Back to searchSign inGet full accessDocta Oy
OYActiveY-tunnus 1943477-3Pl 10Hospital activities · NACE 8610Est. 2005— employees
Revenue 2025
EUR 757K
-21% vs 2024
EBITDA margin
-2.1%
-620% vs 2024
Equity ratio
34.2%
Financial strength
Net profit 2025
EUR -17K
-1308% vs 2024
| Revenue | EUR 757K | -21% |
| EBITDA | EUR -16K | -620% |
| Net profit | EUR -17K | -1308% |
| Total assets | EUR 295K | +5% |
| Equity | EUR 101K | -15% |
| Employees | — | — |
Legal name
Docta Oy
Y-tunnus number
1943477-3
Legal form
Osakeyhtiö
NACE code
8610 · Hospital activities
Founded
25. tammikuuta 2005
Share capital
EUR 200 000
Employees
—
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Hallituksen puheenjohtaja ja toimitusjohtaja kumpikin yksin ja hallituksen jäsenet kaksi yhdessä
Company purpose
Yhtiön toimiala on terveydenhuollon palveluiden, erityisesti leikkauspalveluiden tuottaminen ja siihen liittyvä toiminta. Lisäksi yhtiö voi omistaa, hallita ja vuokrata toiminnassaan tarpeellisia kiinteistöjä tai sellaisen hallintaan oikeuttavia osakkeita.
Address
Pl 10
Phone
+358083152011
Email
kirjaamo@ppshp.fi
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 290 | 0 | 959 | 757 |
| Staff expenses | — | — | — | −29 | −293 | −0 | −852 | −690 |
| EBITDA | −2 | −1 | −1 | −43 | −54 | 0 | 3 | −16 |
| Depreciation & amort. | — | — | — | — | — | −0 | −0 | −0 |
| EBIT | −2 | −1 | −1 | −43 | −54 | 0 | 3 | −16 |
| Net financials | — | — | — | — | −2 | 0 | −2 | −2 |
| Profit before tax | −2 | −1 | −1 | −43 | −56 | 0 | 1 | −17 |
| Tax | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| Net profit | −2 | −1 | −1 | −43 | −56 | 0 | 1 | −17 |
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total assets | 125 | 123 | 122 | 94 | 259 | 0 | 281 | 295 |
| Equity | 125 | 123 | 122 | 79 | 200 | 0 | 118 | 101 |
| Long-term debt | — | — | — | — | — | 0 | 83 | 83 |
| Short-term debt | 0 | 0 | 0 | 15 | 59 | 0 | 79 | 111 |
| Total debt | 0 | 0 | 0 | 15 | 59 | 0 | 162 | 195 |
EBITDA margin
-2.1%
This company
15.8%
Market median
-113% vs market
20182025
Equity ratio
34.2%
This company
38.2%
Market median
+10% vs market
20182025
Return on equity
-17.2%
This company
18.4%
Market median
-193% vs market
20182025
Net profit margin
-2.3%
This company
8.1%
Market median
-128% vs market
20182025
Asset turnover
2.56×
This company
1.12×
Market median
+129% vs market
20182025
Debt / equity
1.93×
This company
0.62×
Market median
-211% vs market
20182025
- Annual report 2025Filed via PRH / YTJ · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via PRH / YTJ · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via PRH / YTJ · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via PRH / YTJ · Period 2018-01-01 – 2018-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
TM Deputy Member | Deputy Member | 2020 | — | — |
MH Deputy Member | Deputy Member | 2020 | — | — |
PE Chief Executive Officer | Chief Executive Officer | 2018 | — | — |
KE Deputy Member | Deputy Member | 2024 | — | — |
EH Chief Executive Officer | Chief Executive Officer | 2021 | — | — |
KP | Audit | 2018 | — | — |
SM Deputy Member | Deputy Member | 2018 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairperson | 2018 | — | — | |
| Board of Directors | 2023 | — | — | |
| Board of Directors | 2018 | — | — | |
| Board of Directors | 2024 | — | — | |
| Board of Directors | 2025 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2018 | — | — | |
| Board of Directors | 2025 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2023 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2018 | — | — | |
| Chairperson | 2024 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Docta Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Tuija Marjatta Holttinen | Deputy Member | 0 companies |
| Merja Hannele Meriläinen | Deputy Member | 0 companies |
| Pasi Ensio Parkkila | Chief Executive Officer | 0 companies |
| Kaj Erik Sundqvist | Deputy Member | 0 companies |
| Erja Helena Jaatinen | Chief Executive Officer | 0 companies |
| Katri Pauliina Hokkanen | Audit | 0 companies |
| Soili Maria Vesterinen | Deputy Member | 0 companies |
| Ilkka Kristian Luoma | Chairperson | 0 companies |
| Juha Jaakko Jääskeläinen | Board of Directors | 0 companies |
| Jari Erkki Jokela | Board of Directors | 0 companies |
| Juha Tapani Korpelainen | Board of Directors | 0 companies |
| Kirsi Johanna Kivelä | Board of Directors | 0 companies |
| Ilkka Eerik Haataja | Board of Directors | 0 companies |
| Heikki Tapani Wiik | Board of Directors | 0 companies |
| Riitta Sisko Luosujärvi | Board of Directors | 0 companies |
| Hanna Leena Maria Rautiainen | Board of Directors | 0 companies |
| Pia Kristiina Peteri | Board of Directors | 0 companies |
| Hanna Maria Raittinen | Board of Directors | 0 companies |
| Riikka Leena Moilanen | Board of Directors | 0 companies |
| Terhi Tuulikki Nevala | Board of Directors | 0 companies |
| Pirjo Kristiina Lukkarila | Board of Directors | 0 companies |
| Kirsti Hannele Ylitalo-Katajisto | Chairperson | 0 companies |